Circulating (cell‐free) nucleic acids – A promising, non‐invasive tool for early detection of several human diseases
Top Cited Papers
- 2 February 2007
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 581 (5), 795-799
- https://doi.org/10.1016/j.febslet.2007.01.051
Abstract
Circulating nucleic acids (CNA) are present in small amounts in the plasma of healthy individuals. However, increased levels of plasma CNA have been reported in a number of clinical disorders like cancer, stroke, trauma, myocardial infarction, autoimmune disorders, and pregnancy‐associated complications. CNA has received special attention because of its potential application as a non‐invasive, rapid and sensitive tool for molecular diagnosis and monitoring of acute pathologies and the prenatal diagnosis of fetal genetic diseases. This review throws light on the current status of blood CNA as a diagnostic marker and its potential as a powerful tool in the future.Keywords
This publication has 23 references indexed in Scilit:
- Fluorometric quantification of RNA and DNA in solutions containing both nucleic acidsAnalytical Biochemistry, 2003
- Prognostic Use of Circulating Plasma Nucleic Acid Concentrations in Patients with Acute StrokeClinical Chemistry, 2003
- Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patientsCancer Letters, 2003
- Circulating DNA: a new diagnostic gold mine?Cancer Treatment Reviews, 2002
- DNA methylation analysis: a powerful new tool for lung cancer diagnosisOncogene, 2002
- Cell-Free DNA in Human Blood PlasmaPancreas, 1998
- Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumoursCancer Letters, 1995
- Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemiaBritish Journal of Haematology, 1994
- Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1966
- THE PURPLE COLOR REACTION GIVEN BY DIPHENYLAMINE REAGENT. I. WITH NORMAL AND RHEUMATIC FEVER SERA 1Journal of Clinical Investigation, 1951